Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-23 | Ms. Maderis holds a BS in business from UC Berkeley and an MBA from Harvard Business School and has held senior executive positions in biopharma. |
| 2022-04-25 | Ms. Maderis holds a B.S. in business from UC Berkeley and an M.B.A. from Harvard Business School. |
| 2023-04-27 | She received a Bachelor of Science in business from the University of California at Berkeley and a Master of Business Administration from Harvard Business School. Ms. Maderis’ operational, industry and leadership experience in the biopharmaceutical industry as Chief Executive Officer of Five Prime Therapeutics, Inc., Founder and President of Genzyme Molecular Oncology and her current position at Antiva, and her insight into business and policy trends impacting the biopharma industry are among the qualifications she brings to our Board of Directors. |
| 2024-08-12 | She received a Bachelor of Science in business from the University of California at Berkeley and a Master of Business Administration from Harvard Business School. |
Data sourced from SEC filings. Last updated: 2026-02-03